Rizatriptan Benzoate recalls

7 recalls on record

Recalled by 1 agency: FDA (7).

First recall on record: November 3, 2021. Most recent: July 23, 2025.

Risk classification: Class II: 6 · Class III: 1

Recalert records 7 recalls for Rizatriptan Benzoate from FDA. The earliest is dated November 3, 2021 and the latest July 23, 2025. 0 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-262-18 (D-0534-2025).

Most recent recalls

Questions about this brand

Does Rizatriptan Benzoate have recalls in 2026?
Recalert records 0 recalls for Rizatriptan Benzoate dated in 2026.

Do you sell Rizatriptan Benzoate products? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related brands